Next-generation immunotherapies for brain metastatic cancers

Area of Science:

• Oncology
• Immunology
• Neuroscience

Background:

• Brain metastases (BM) are a frequent complication in patients with extracranial tumors, including lung, breast, and skin cancers.
• BM often signify advanced cancer and pose significant therapeutic challenges.
• Recent advancements in understanding BM immune biology have spurred interest in immunotherapy.

Purpose of the Study:

• To review the pathobiology of brain metastases progression.
• To evaluate the potential of next-generation immunotherapies for BM tumors.
• To provide future perspectives on developing and implementing these therapies for brain metastatic cancer patients.

Main Methods:

• Literature review of pathobiology of BM progression.
• Evaluation of current and emerging immunotherapies for BM.
• Analysis of future directions in BM treatment.

Main Results:

• BM development is a critical step in cancer progression.
• Various immunotherapies, including cell-targeting, virotherapy, vaccines, and cell-based therapies, show promise for BM.
• Further research is needed to optimize these treatments.

Conclusions:

• Understanding BM pathobiology is crucial for effective treatment.
• Next-generation immunotherapies offer new hope for patients with brain metastases.
• Collaborative efforts are essential for advancing immunotherapy for brain metastatic cancer.